Internship
Develops cloud-connected medical devices for chronic diseases
$22.50 - $41.50/hr
No H1B Sponsorship
San Diego, CA, USA
This is a hybrid role requiring some on-site team meetings.
Get referrals →
You have ways to get a Resmed referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 7 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
ResMed develops medical devices and software platforms that help treat and manage conditions like sleep apnea and chronic obstructive pulmonary disease (COPD). Their products are cloud-connected, allowing for better monitoring and management of patients' health. ResMed's offerings include both medical devices and software subscriptions, which provide ongoing support and services. What sets ResMed apart from its competitors is its focus on reducing hospital visits and healthcare costs while improving the quality of life for patients. The company's goal is to enhance patient care and support healthcare professionals and caregivers across more than 120 countries.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
San Diego, California
Founded
1989
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
Parental Leave
401(k) Retirement Plan
Employee Assistance Program (EAP)
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions.The acquisition reflects Resmed’s commitment to improving the way care is delivered—by making it more accessible, more coordinated, and more patient friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to support patients earlier in their journey and help healthcare providers and homecare companies deliver care in a simpler, more connected way.VirtuOx’s virtual testing platform helps reduce barriers to diagnosis, offering fast, flexible, and affordable options for patients—particularly those with sleep-disordered breathing or other conditions that are often underdiagnosed. For people suspected of having obstructive sleep apnea (OSA), a more streamlined, digital-first experience can make the difference between following through on testing and treatment—or falling out of the care pathway entirely.“This is about creating a simpler, more connected pathway to care,” said Justin Leong, Chief Product Officer at Resmed. “By integrating VirtuOx’s diagnostic capabilities into our ecosystem, we can help accelerate the time between evaluation and treatment, reduce drop-off, and help more people access the life-changing benefits of therapy for sleep apnea and related conditions.”This acquisition strengthens Resmed’s ability to partner with healthcare providers to help streamline the diagnostic process and alleviate current bottlenecks, while expanding collaboration with home medical equipment providers to efficiently and expeditiously support patients to start treatment. It further enhances the company’s ability to serve healthcare providers with integrated tools that improve care coordination, patient engagement, and outcomes.“VirtuOx and Resmed are aligned in our focus to simplify healthcare and expand access,” said Steve Lica, CEO of VirtuOx. “Joining Resmed gives us the opportunity to scale our impact, reach and help more patients, and keep innovating on behalf of the providers and health systems we serve.”The acquisition supports a growing demand for home-based care—driven by increased awareness, convenience, and digital innovation
Healthcare technology provider Resmed has named Salli Schwartz as its chief investor relations officer.
ResMed was also recognized as one of LexisNexis "Top 100 Global Innovators."
Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.
SAN DIEGO - Medtrade exhibitor Resmed has launched NightOwl(TM), a new home sleep apnea test (HSAT) that is now available across the United States.